Clinical Trial

Insulin Delivery Using the DBLG1 Closed-loop on Glycemic Control and PROMs in Adults Living With Type 1 Diabetes

Study acronym: INLOOP
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2023 (before its estimated July 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the impact of the DBLG1 hybrid closed-loop system on glycemic control and patient-reported outcomes in adults living with type 1 diabetes under real-life conditions.
Protocol Amendment History 1 change
critical Trial status changed: Enrolling by Invitation → Unknown 2026-08-02
Trial Details
NCT Number NCT06154135
Lead Sponsor Erasme University Hospital
Conditions Diabetes Mellitus, Type 1
Enrollment 165 participants
Start Date 2022-12-30
Primary Completion 2024-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2023-12-12